Ann: Expanded collaboration with Siemens Healthineers to US, page-86

I’ve only been in lrs since early last year so can’t comment on their history. However I have loved their communication and how fast they turn around core visuals and lab results. No wonder they have gone from 3.5c to 36c in that time.

have been in Ibx just pre ethics committee approval. All I’ve seen since is poor strategy and mismanagement. Not surprisingly share price has tanked and options were so far out of the money. I can’t see how anyone sees the current share price as anything other than a failed investment.

Also there’s a bit of difference between scratching around in the dirt looking for paydirt vs executing a trial phase 1 trial whose end point was safety, not efficacy.

all my opinion based on my experience